1. P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS. (23rd June 2022) Authors: Kiladjian, J.-J.; Tefferi, A.; Passamonti, F.; Vannucchi, A.; Talpaz, M.; Cervantes, F.; Harrison, C. N.; Mesa, R. A.; Mascarenhas, J.; Schaap, N.; Verstovsek, S.; Devos, T.; Rose, S.; Zhang, J.; Sy, O.; Pardanani, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT. (23rd June 2022) Authors: Tilmont, R.; Yakoub-Agha, I.; Eikema, D.-J.; Zinger, N.; Haenel, M.; Schaap, N.; Herrera Arroyo, C.; Schuermans, C.; Bethge, W.; Engelhardt, M.; Kuball, J.; Michieli, M.; Schub, N.; Wilson, K. M. O.; Bourhis, J. H.; Mateos, M. V.; Robin, N.; Jost, E.; Kröger, N.; Moraleda, J. M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PV-0042: Fractionated-TBI schedules prior to allograft: Study from the Acute Leukemia Working Party (EBMT). (May 2017) Authors: Belkacemi, Y.; Labopin, M.; Giebel, S.; MiszyK, L.; Loganadane, G.; Michallet, M.; Socié, G.; Schaap, N.; Cornelissen, J.; Yakoub-Agha, I.; Nagler, A. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗